New guidelines tackle pre-eclampsia

A new guideline published in this week's BMJ will help to tackle one of the leading causes of illness and death during pregnancy.

Pre-eclampsia is a serious condition in which abnormally high blood pressure and many other disturbances develop in the second half of pregnancy. It affects about seven per cent of pregnancies and is dangerous for both mother and child.

The most important risk factor for developing pre-eclampsia is a previous history, show researchers at the John Radcliffe Hospital in Oxford. Diabetes and a high body mass index almost quadruple the risk, while mother's age and raised blood pressure are also significant.

Many fetal and maternal deaths from pre-eclampsia are associated with substandard care, claim the guideline authors. Poor management includes failure to identify or act on risk at the beginning of pregnancy or to recognise and respond to signs and symptoms after 20 weeks.

Their guideline recommends a straightforward system of early risk assessment and referral to ensure that pregnant women with pre-eclampsia are offered specialist care at the appropriate time for the best outcome for them and their baby.

It is aimed at those caring for pregnant women in the community and is a practical extension of NICE's antenatal guideline.

An accompanying editorial applauds the simplicity and practicality of the new guideline. "We cannot be complacent in the face of the recurrent deficiencies" writes Ian Greer, Professor of Obstetrics and Gynaecology at the University of Glasgow. "The pragmatic approach of PRECOG is essential because pre-eclampsia matters."

Click here to view full paper (PDF)
Click here to view full guideline (PDF)
Click here to view full editorial (PDF)


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Garlic proves potent in reducing blood sugar and cholesterol, study reveals